Seismic Therapeutic
Andre S. has worked in various roles in the scientific field since 2012. Andre began as a Postdoctoral Researcher at Kyoto University, then moved on to become a Visiting Research Fellow at the National Cancer Institute (NCI) in 2014. In 2015, they became a Long-term Postdoctoral Fellow (LTF) at HUMAN FRONTIER SCIENCE PROGRAM (HFSP). From 2019 to 2022, they were a Principal Scientist and Senior Scientist at Pfizer. Currently, they are a Principal Scientist at Seismic Therapeutic.
Andre S. attended St. Andrew's School, Singapore for their high school education. Andre then went on to receive a Bachelor of Science in Biochemistry and Cell Biology from UC San Diego in 2006. Afterwards, they pursued a Doctor of Philosophy in molecular immunology from Kyoto University, which they completed in 2012.
Seismic Therapeutic
1 followers
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.